This Program Project proposes an integrated investigation of molecular genetic, biochemical, serological and functional aspects of the human major histocompatibility complex (HLA) and HLA antigen interactions with T- lymphocytes. The overall objective is to obtain a better understanding of the function of the HLA genes and their gene products. This includes the analysis of regulation of HLA gene expression and function of the HLA antigens particularly as they relate to T-lymphocyte activation and generation of helper T cells and cytotoxic T-cells. This program aims at gaining basic information about allograft reactions and to obtain a better understanding of the underlying mechanisms for the relationship between HLA gene products, and T-cells, B cells and antigen presenting cells. The program is composed of one Core Component for common reagents and administrative Resources and five projects. The five projects are entitled: (1) T Lymphocyte Activation by Alloantigens. (3) Factors Controlling HLA Class I Expression. (4) Genes controlling HLA Class II Expression in Lymphocytes. (5) Regulation and Function of Human CD4. We will in the first project investigate the different requirements for primary alloantigen activation of T-cells, in contrast to the requirements for secondary alloantigen activation. The involvement of CD2, CD45 and CD28 on the T-cells during alloactivation in vitro is the major aim of the study. The basic question of restriction of murine T-cells to transgenic xeno MHC and peripheral tolerance will be investigated in the second project. This will be investigated using HLA transgenic mice. The third and fourth projects involve investigations of gene regulation of HLA class I and HLA class II respectively. The fifth project concerns the investigation of regulation and function of CD4 during T-cell maturation in the thymus. This program aims at gaining basic information about allograft reactions and to obtain a better understanding of the underlying mechanisms for the relationshipH48789 36of social cognition.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
2P01CA022507-14A1
Application #
3093002
Study Section
Special Emphasis Panel (SRC (I1))
Project Start
1978-01-01
Project End
1995-12-31
Budget Start
1992-01-03
Budget End
1992-12-31
Support Year
14
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
King, P D; Sadra, A; Teng, J M et al. (1997) Analysis of CD28 cytoplasmic tail tyrosine residues as regulators and substrates for the protein tyrosine kinases, EMT and LCK. J Immunol 158:580-90
Selvakumar, A; Steffens, U; Dupont, B (1996) NK cell receptor gene of the KIR family with two IG domains but highest homology to KIR receptors with three IG domains. Tissue Antigens 48:285-94
August, A; Dupont, B (1996) Association between mitogen-activated protein kinase and the zeta chain of the T cell receptor (TcR) with the SH2,3 domain of p56lck. Differential regulation by TcR cross-linking. J Biol Chem 271:10054-9
Gibson, S; August, A; Kawakami, Y et al. (1996) The EMT/ITK/TSK (EMT) tyrosine kinase is activated during TCR signaling: LCK is required for optimal activation of EMT. J Immunol 156:2716-22
Teng, J M; King, P D; Sadra, A et al. (1996) Phosphorylation of each of the distal three tyrosines of the CD28 cytoplasmic tail is required for CD28-induced T cell IL-2 secretion. Tissue Antigens 48:255-64
Teng, J M; Liu, X R; Mills, G B et al. (1996) CD28-mediated cytotoxicity by the human leukemic NK cell line YT involves tyrosine phosphorylation, activation of phosphatidylinositol 3-kinase, and protein kinase C. J Immunol 156:3222-32
King, P D; Sadra, A; Han, A et al. (1996) CD2 signaling in T cells involves tyrosine phosphorylation and activation of the Tec family kinase, EMT/ITK/TSK. Int Immunol 8:1707-14
Gibson, S; August, A; Branch, D et al. (1996) Functional LCK Is required for optimal CD28-mediated activation of the TEC family tyrosine kinase EMT/ITK. J Biol Chem 271:7079-83
Bannish, G; Hume, C; Lee, J S (1996) Coordinate regulation of HLA class II genes: a novel DNA binding complex. Mol Immunol 33:407-15
August, A; Dupont, B (1995) Activation of extracellular signal-regulated protein kinase (ERK/MAP kinase) following CD28 cross-linking: activation in cells lacking p56lck. Tissue Antigens 46:155-62

Showing the most recent 10 out of 103 publications